Assessment of the HScore as a predictor of disease outcome in patients with COVID-19

Abstract Severe coronavirus disease 2019 (COVID-19) accompanies hypercytokinemia, similar to secondary hemophagocytic lymphohistiocytosis (sHLH). We aimed to find if HScore could predict disease severity in COVID-19. HScore was calculated in hospitalized children and adult patients with a proven dia...

Full description

Bibliographic Details
Main Authors: Mohammadreza Bordbar, Anahita Sanaei Dashti, Ali Amanati, Eslam Shorafa, Yasaman Mansoori, Seyed Javad Dehghani, Hossein Molavi Vardanjani
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-021-01706-0